Child and adolescent mental health problems are common in the community, but the scientific basis for the treatment of many of these conditions is still in its infancy. Conditions for which a moderate level of skill in pharmacological management is required include obsessivecompulsive disorder, tic disorders, attention deficit hyperactivity disorder in the primary school-aged child, and persistent enuresis. Greater skill is required in the treatment of anxiety disorders, depression, attention deficit hyperactivity disorder in teenagers, and aggressive behaviour associated with autism and intellectual disability. Only clinicians with advanced skills should consider treating juvenile onset bipolar affective disorder, children with psychotic-like symptoms, and attention deficit hyperactivity disorder in preschoolers or in children with intellectual disability.
Introduction
'You are always on your own when prescribing psychotropic medication to children.' This statement was made, not by a general practitioner or a paediatrician, but by a leading paediatric psychopharmacologist.
It is a pithy reminder that the scientific basis to the pharmacological management of children with psychiatric conditions is limited and that institutional support for such prescribing is qualified. This said, there is good evidence for the pharmacological management of some childhood disorders.
Psychiatric disorders in childhood are too common for treatment to be the exclusive domain of specialist services. Several conditions can be managed by general practitioners depending on their level of skill. However, many general practitioners report limited exposure to child and adolescent psychiatric problems in their undergraduate and postgraduate training. 
General considerations

Conditions requiring a moderate skill level
These conditions are usually easy to recognise and have proven treatments.
Obsessive compulsive disorder
The content of the obsessions, particularly if they are of a sexual nature, can be distressing and may lead to secondary depression. Obsessive compulsive disorder can be very disabling.
Obsessive compulsive disorder responds well to cognitive behaviour therapy, the selective serotonin reuptake inhibiting drugs such as sertraline and fluvoxamine, and the serotonergically active tricyclic clomipramine. 2 The doses required to achieve remission may be higher than those used in the treatment of childhood depression. Once symptoms are suppressed treatment should be continued for at least 12 months to minimise relapse. 
Tourette's syndrome
Attention deficit hyperactivity disorder (ADHD)
In carefully selected children aged 6-12 years ADHD responds well to the psychostimulants methylphenidate or dexamphetamine. These are well-researched medications and are relatively safe if used appropriately. 3 In many states 
Enuresis
Bedwetting that has not responded to behavioural treatments, including the 'bell and pad', may respond to medication.
Although tricyclic antidepressant drugs are effective for this condition, their benefit does not justify the risk when safer alternatives, such as intranasal desmopressin, are available.
Conditions requiring a medium to high skill level
These conditions may have a wide differential diagnosis or require complex therapy.
Anxiety
Anxiety disorders are common in children, but often cause only mild impairment and respond well to psychological treatments.
They therefore rarely warrant pharmacological treatment.
Indications for medication include school refusal that is unresponsive to other treatments and the incapacitating anxiety that occurs in panic disorder. 
Depression
Depression in children and adolescents can be overlooked as it often has an insidious onset and is characterised by irritability rather than low mood. By the time the patient is evaluated by a doctor the symptoms may have been present for many months.
There is no need to rush into treatment. It is wise to review the mood state of the patient on at least two occasions before recommending pharmacotherapy. The Adverse Drug Reactions
Advisory Committee recommends that drugs should only be used as part of a comprehensive management program. 4 Fluoxetine is the only antidepressant considered from trial evidence to possibly have a satisfactory risk:benefit ratio in this age group. 5 Patients should be monitored regularly during the first weeks of treatment for the emergence of agitation, suicidal thoughts or intent, or self-harming behaviour, as one in 20 will develop problems. Remission of depressive symptoms may take up to three months. Treatment should be continued for at least nine months after remission has been achieved.
ADHD in adolescents
ADHD persisting into adolescence is the rule rather than the exception, but patients may find it difficult to access specialist services for treatment. Psychostimulant drugs remain the first-line treatment, but some patients complain of adverse effects including dysphoria. Teenage patients may be pressured to give or sell their tablets to peers. For such reasons some adolescent patients need to switch to one of the non-stimulant treatments. ADHD presenting for the first time in adolescence is atypical and warrants a specialist assessment.
Aggressive behaviours associated with autism and intellectual disability
Aggression arises from a combination of limited problemsolving skills and a low threshold to arousal. Medicines are not first-line treatment, however controlled trials have found risperidone superior to placebo in treating such symptoms. 6 In my experience, while the initial impact on behaviours can be dramatic, the effectiveness of risperidone usually declines over time. For this reason the benefit of continuing treatment should be reviewed every three to six months. Other atypical antipsychotics and pericyazine are prescribed for the same indication, but the evidence is less robust. Clonidine as a monotherapy offers an alternative strategy for reducing arousal.
Patients whose aggression arises in the context of obsessive compulsive disorder-like behaviour may respond to SSRIs.
Conditions requiring advanced skills
General practitioners should only consider these treatment options if they have had specific training or if they work in close collaboration with child mental health services.
ADHD in preschoolers and the intellectually disabled
The evidence base for the efficacy of pharmacological treatments in preschool children is limited. Young children are more prone than older children to experience adverse effects with methylphenidate. Psychostimulant medication will alleviate hyperactive behaviours in children with autism or intellectual disability, but may exacerbate obsessive compulsive disorderlike behaviours.
Juvenile onset bipolar affective disorder
This diagnosis is controversial, yet most people with bipolar 
Conclusion
Psychiatric disorders are common in childhood. While many problems can be managed without drugs, some conditions require pharmacotherapy. However, the evidence supporting this therapy in children is often limited. Some conditions can be successfully managed by the general practitioner provided they have the appropriate level of skill. 
Further reading
Self-test questions
The following statements are either true or false 
